Welcome to our dedicated page for Nocera SEC filings (Ticker: NCRA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Nocera, Inc. (NASDAQ:NCRA) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures, including registration statements, current reports, and proxy materials. These documents explain how Nocera structures its financing, describes its aquaculture and acquisition-focused business, and outlines key shareholder proposals.
Among the notable filings are registration statements on Form S-1 and amendments, which describe Nocera’s business overview, including its focus on designing, developing and producing large-scale recirculating aquaculture systems (RASs) and providing consulting, technology transfer, and project management services for aquaculture facilities. These filings also detail offerings of common stock issuable upon conversion of Series B Convertible Non-Voting Preferred Stock.
Nocera’s Current Reports on Form 8-K document material events such as entry into securities purchase agreements for senior secured convertible notes with an institutional investor, the creation of direct financial obligations, and the terms under which these notes convert into common stock. Other 8-K filings describe the issuance of Series B Preferred Stock, related registration rights agreements, and executive employment agreements.
The company’s definitive proxy statement on Schedule 14A outlines matters submitted to shareholders, including the election of directors, ratification of the independent auditor, approval of potential share issuances upon conversion of preferred stock and senior secured convertible notes, and proposed amendments to its articles of incorporation for a reverse stock split and an increase in authorized common shares.
On Stock Titan, these filings are updated from the SEC’s EDGAR system and can be paired with AI-powered summaries that highlight key terms, capital structure changes, conversion mechanics, and shareholder authorization requests. Users can quickly locate annual and quarterly reporting referenced in proxy materials, review the details of convertible instruments and preferred stock designations, and examine how Nocera’s governance and financing decisions are presented in its official SEC documents.
Nocera, Inc. (NCRA) filed a Form S-8 to register 6,666,667 shares of common stock for issuance under its 2018 Stock Option and Award Incentive Plan. The plan was approved effective December 31, 2018 and permits incentive stock options, non-qualified options, and stock purchase rights for employees, consultants, and directors.
The company states it had not previously filed an S-8 for this plan; this filing registers the entire 6,666,667 shares authorized under the 2018 plan. The plan is administered by the company’s Compensation Committee, and the filing incorporates by reference recent 10-K, 10-Q, and 8-K reports.
Nocera, Inc. (NCRA) is registering shares in an S-1 offering and describes an aquaculture-focused business providing turnkey recirculating aquaculture system (RAS) solutions, pilot and management services, and select equipment and materials for fish and shrimp farming. The filing shows corporate actions including VIE agreements giving the company control of Xinca (1,800,000 shares issued) and a prior Equity Purchase Agreement for SY Culture that was sold on June 5, 2025 for $550,000 (approximately $500,000 collected by June 30, 2025 and $50,000 received in July 2025). The company completed a prior public offering that issued 1,880,000 common shares at $3.50 per share for gross proceeds of $6.58 million and net proceeds of approximately $5.3 million. Financials show significant goodwill balances related to acquisitions (goodwill totals reported over $1.8M to $3.0M in various periods) and large impairment charges aggregated in the filing (examples include impairments of $1,159,172 and $2,250,553 in periods shown, and consolidated impairment totaling multi-million dollars). The filing reports material net losses (examples: net loss figures of $(502,645) for a period and consolidated net losses shown as $(4,159,354) and similar large year-to-date losses) and negative retained earnings balances. The capital structure includes common stock outstanding (14,367,539 shares as of June 30, 2025), 80,000 Series A preferred shares outstanding, multiple classes of warrants exercisable at various prices, and up to 45,000,000 shares offered by a selling stockholder. The filing discloses concentrations of receivables and customer percentages and describes audit and governance arrangements, management and executive officers by name.
Nocera, Inc. filed a Form 8-K reporting the execution of two employment agreements dated September 2, 2025 with Andy Jin and Andrew Teng. The filing identifies the company's common stock (ticker NCRA) traded on The Nasdaq Stock Market. The report lists Exhibits 10.1 and 10.2 as the two employment agreements and Exhibit 104 as the cover page interactive data file. The document is signed by Andy Ching-An Jin and filed on September 3, 2025. No financial terms, roles, or additional transaction details are included in the provided content.
Nocera, Inc. disclosed a material corporate financing event in an 8-K, attaching the governing documents for a new Series B Convertible Non-Voting Preferred Stock and related investor agreements. The filing includes the Certificate of Designation establishing the preferred series, a Securities Purchase Agreement between the company and an investor, and a Registration Rights Agreement that governs resale registration rights. These exhibits indicate the company is issuing preferred equity and documenting investor subscription and registration terms; specific economic terms, investor identity, and share counts are not included in the provided text.
Nocera, Inc. reported interim condensed results showing substantial operating losses and corporate transactions in first half 2025. Total current assets included amounts such as $109,951 and $144,509 (various line items), with property and equipment of approximately $1,010,919 and goodwill largely related to acquisitions totaling $1,351,703 for Xinca. The company recognized significant segment and consolidated losses, including a net loss of $(502,645) for a reported period and larger year-to-date losses such as $(760,262) and $(816,157) in comparative tables. Capital activity included issuance of shares (14,367,539 common shares outstanding as of June 30, 2025), warrant exercises, and a public offering that generated gross proceeds of $6.58 million (net proceeds ~ $5.3 million). Corporate transactions: the company obtained 100% control of Xinca via issuance of 1,800,000 restricted common shares, acquired Meixin with an 80% interest for $4,300,000 (via VIE agreements), and sold SY Culture on June 5, 2025 for $550,000 ($500,000 collected by June 30, 2025 with $50,000 received in July). Management disclosed internal control weaknesses and remediation plans to strengthen financial reporting, IT controls and policies.
Nocera, Inc. (symbol: NCRA) filed an amended Form 10-K (10-K/A) dated 6 May 2025 to restate Note 25 – Segment Reporting for the fiscal year ended 31 December 2024. The XBRL excerpt shows the company reclassified and re-tagged data across multiple equity classes (Common Stock, Series A Preferred, additional paid-in capital, statutory reserves, accumulated other comprehensive income, non-controlling interests) and identified three primary operating segments – Fish Trading, Catering, and E-Commerce – along with an “All Segments” consolidation member.
The amendment introduces srt:RestatementAdjustmentMember tags for full-year 2022 and 2023 and for each 2024 interim period, paired with srt:ScenarioPreviouslyReportedMember tags, indicating comparative figures have been corrected. Numerous customer, supplier, and geographic concentration members (e.g., Five Customer, Supplier A, country:CN) are listed, suggesting enhanced disclosure of concentration risks, although no quantitative revenue, profit, or cash-flow amounts are provided in the excerpt.
The filing appears limited to correcting segment-level disclosure errors; no additional narrative, financial statements, or earnings data are included here. Investors should review the full 10-K/A to understand the magnitude of the adjustments and any potential control deficiencies that led to the restatement.